RAWAHN LATEEF SAEED

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Primary Care DEARBORN HEIGHTS, MI NPI 1306699731

General Payments — all program years on this page

$301.55

  • Category: General Payments
  • Program years: PY2024
  • Record count: 16
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $301.55 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $301.5516

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
ABBVIE INC. $106.985
Acerta Pharma LLC $66.834
Sumitomo Pharma America, Inc. $31.201
Lundbeck LLC $30.502
ITI, Inc. $20.381
Novo Nordisk AS $17.641
Lilly USA, LLC $14.941
Boehringer Ingelheim Pharmaceuticals, Inc. $13.081

By program year

Program yearAmountRecords
2024 $301.5516

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100632695 Novo Nordisk Inc $17.64 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104573546 AstraZeneca Pharmaceuticals LP $15.52 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104661365 AstraZeneca Pharmaceuticals LP $17.87 09/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105429304 AstraZeneca Pharmaceuticals LP $15.93 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105650582 AstraZeneca Pharmaceuticals LP $17.51 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108132540 ABBVIE INC. $27.38 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108132542 ABBVIE INC. $24.39 07/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108132544 ABBVIE INC. $17.54 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108132546 ABBVIE INC. $14.35 10/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108132548 ABBVIE INC. $23.32 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117956874 Boehringer Ingelheim Pharmaceuticals, Inc. $13.08 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135925686 Lilly USA, LLC $14.94 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143596062 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.38 12/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146085141 Lundbeck LLC $13.45 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146085143 Lundbeck LLC $17.05 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148992410 Sumitomo Pharma America, Inc. $31.20 11/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.